4.180USD-5.00%Mkt Cap: 336.98M USDP/E: —Last update: 2026-06-01
Opus Genetics, Inc., a clinical-stage biopharmaceutical company, develops gene therapies to restore vision and prevent blindness in patients with inherited retinal diseases (IRDs) and other types of therapies for additio…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap336.98M USD
Enterprise Value277.29M USD
Revenue (TTM)11.98M USD
Gross Profit-18.83M USD
Net Income (TTM)-49.59M USD
Revenue/Share0.1590 USD
Last Price4.180 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees27
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-6.21
PEG—
EV/EBITDA-6.45
EV/Revenue23.14
P/S29.62
P/B-6.79
EPS (TTM)-1.31
EPS (Forward)-0.70
52W Range
0.900067% of range5.810
52W High5.810 USD
52W Low0.9000 USD
Profitability
Gross Margin-157.13%
Oper. Margin-665.92%
EBITDA Margin0.00%
Profit Margin-349.33%
ROE-323.11%
ROA-98.70%
Growth
Revenue Growth-50.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-35.25M USD
CapEx (TTM)—
FCF Margin—
FCF Yield—
Net Debt-58.76M USD
Net Debt/EBITDA1.37
Balance Sheet
Debt/Equity0.07
Current Ratio7.13
Quick Ratio6.71
Book Value/Sh-0.6420 USD
Cash/Share0.8400 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateNov 6, 2020
Splits
Last Split1:4
Split DateNov 6, 2020
Analyst Consensus
Rating1.1 (Strong Buy)
Target (Mean)10.13 USD
Target Range8.000 USD – 15.00 USD
# Analysts16
Ownership
Shares Out.81.40M
Float34.48M
Insiders11.22%
Institutions55.81%
Short Interest
Short Ratio3.3d
Short % Float4.02%
Short % Out.3.82%
Shares Short3.11M
Short (prev mo.)1.81M
Technical
SMA 504.909 (-14.8%)
SMA 2002.943 (+42.0%)
Beta—
S&P 52W Chg27.94%
Avg Vol (30d)903.95K
Avg Vol (10d)818.79K
Technical Indicators
RSI (14)42.3
MACD-0.2250
MACD Signal-0.1662
MACD Hist.-0.0588
BB Upper5.630 USD
BB Middle4.744 USD
BB Lower3.857 USD
BB Width37.37%
ATR (14)0.3078 USD
Vol Ratio (20d)0.87x